Suppression of EphB4 improves the inhibitory effect of mTOR shRNA on the biological behaviors of ovarian cancer cells by down-regulating Akt phosphorylation

[1]  Emma E Vincent,et al.  Akt signalling in health and disease. , 2011, Cellular signalling.

[2]  Shereen R Kadir,et al.  Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells , 2010, Nature Cell Biology.

[3]  A. Sood,et al.  Converging Evidence for Efficacy from Parallel EphB4-Targeted Approaches in Ovarian Carcinoma , 2010, Molecular Cancer Therapeutics.

[4]  A. Caflisch,et al.  Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4). , 2009, Journal of medicinal chemistry.

[5]  Andrew J. Wilson,et al.  The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. , 2009, Cancer research.

[6]  B. Barlogie,et al.  The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. , 2009, Blood.

[7]  T. Tamaya,et al.  Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers , 2008, British Journal of Cancer.

[8]  L. Helman,et al.  Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism , 2007, Oncogene.

[9]  J. Brown,et al.  Tumor Necrosis Factor-α-stimulated Cell Proliferation Is Mediated through Sphingosine Kinase-dependent Akt Activation and Cyclin D Expression* , 2007, Journal of Biological Chemistry.

[10]  Jiaoti Huang,et al.  Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway Is Essential for Neuroendocrine Differentiation of Prostate Cancer* , 2006, Journal of Biological Chemistry.

[11]  Shile Huang,et al.  Curcumin inhibits the mammalian target of rapamycin‐mediated signaling pathways in cancer cells , 2006, International journal of cancer.

[12]  Chuanshu Huang,et al.  Participation of the PI-3K/Akt-NF-κB signaling pathways in hypoxia-induced mitogenic factor-stimulated Flk-1 expression in endothelial cells , 2006, Respiratory research.

[13]  J. Nesland,et al.  The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma. , 2006, Gynecologic oncology.

[14]  G. Mills,et al.  Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma , 2006, Molecular Cancer Therapeutics.

[15]  J. Stein,et al.  EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival , 2006, Oncogene.

[16]  R. Adams,et al.  Ephrin-B2 Controls Cell Motility and Adhesion during Blood-Vessel-Wall Assembly , 2006, Cell.

[17]  Mitsutoshi Nakada,et al.  EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. , 2005, The American journal of pathology.

[18]  Xiang-yi Ma,et al.  Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides. , 2005, Oncology reports.

[19]  J. Lingrel,et al.  Induction of KLF2 by Fluid Shear Stress Requires a Novel Promoter Element Activated by a Phosphatidylinositol 3-Kinase-dependent Chromatin-remodeling Pathway* , 2005, Journal of Biological Chemistry.

[20]  David A Foster,et al.  Alternative phospholipase D/mTOR survival signal in human breast cancer cells , 2005, Oncogene.

[21]  Xianglin Shi,et al.  G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. , 2004, American journal of physiology. Cell physiology.

[22]  D. Shegogue,et al.  Mammalian Target of Rapamycin Positively Regulates Collagen Type I Production via a Phosphatidylinositol 3-Kinase-independent Pathway* , 2004, Journal of Biological Chemistry.

[23]  E. Pasquale,et al.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Guoyao Wu,et al.  Eph B4 Receptor Signaling Mediates Endothelial Cell Migration and Proliferation via the Phosphatidylinositol 3-Kinase Pathway* , 2002, The Journal of Biological Chemistry.

[25]  Alfonso Bellacosa,et al.  AKT plays a central role in tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Volker Patzel,et al.  Theoretical design of antisense genes with statistically increased efficacy , 2000, Nucleic Acids Res..

[27]  Domenico Coppola,et al.  Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer , 2000, Oncogene.

[28]  J. Cheng,et al.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Santhosh K. P. Kumar,et al.  The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. , 2009, Blood.